Guideline Concordance of Statin Treatment Decisions: A Retrospective Cohort Study

Guideline Concordance of Statin Treatment Decisions: A Retrospective Cohort Study

Guidelines recommend initiation of statins depending on cardiovascular risk and low-density lipoprotein cholesterol (LDL-C) levels. In this retrospective cohort study, we aimed to assess guideline concordance of statin treatment decisions and to find determinants of undertreatment in Swiss primary c...

Full description

Bibliographic Details
Main Authors:	Yael Rachamin, Stefan Markun, Thomas Grischott, Thomas Rosemann, Rahel Meier
Format:	Article
Language:	English
Published:	MDPI AG 2020-11-01
Series:	Journal of Clinical Medicine
Subjects:	guideline adherence statins cardiovascular diseases low-density lipoprotein cholesterol prevention
Online Access:	https://www.mdpi.com/2077-0383/9/11/3719

Similar Items

Statin treatment and LDL target value achievement in Swiss general practice – a retrospective observational study
by: Yael Rachamin, et al.
Published: (2020-05-01)

Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines
by: Levintow SN, et al.
Published: (2020-08-01)

The Impact of the 2019 European Guideline for Cardiovascular Risk Management: A Cross-Sectional Study in General Practice
by: Rahel Meier, et al.
Published: (2020-07-01)

Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia
by: Alwhaibi M, et al.
Published: (2019-12-01)

Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low‐Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients
by: Ted Okerson, et al.
Published: (2017-03-01)

Statin therapy in multimorbid older patients with polypharmacy- a cross-sectional analysis of the Swiss OPERAM trial population
by: Luise Adam, et al.
Published: (2023-09-01)

Prevalence of dyslipidemia in statin-treated patients in the Baltic states (Estonia, Latvia, and Lithuania): Results of the Dyslipidemia International Study (DYSIS)
by: Margus Viigimaa, et al.
Published: (2014-01-01)

Association of Primary Care Providers’ Beliefs of Statins for Primary Prevention and Statin Prescription
by: Jeffrey D. Clough, et al.
Published: (2019-02-01)

Response by sex to statin plus ezetimibe or statin monotherapy: A pooled analysis of 22,231 hyperlipidemic patients
by: Lin Jianxin, et al.
Published: (2011-08-01)

Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease
by: Miao Wang, et al.
Published: (2020-06-01)

High‐Intensity Versus Non‐High‐Intensity Statins in Patients Achieving Low‐Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention
by: Juwon Kim, et al.
Published: (2018-11-01)

Do statins benefit low-risk population for primary prevention of atherosclerotic cardiovascular disease: A retrospective cohort study
by: In Sun Ryou, et al.
Published: (2022-11-01)

Association of serum cholesterol with Parkinson's disease in a cohort of statin‐free individuals
by: Yukai Lv, et al.
Published: (2022-01-01)

Association of PCSK9 Inhibitor Initiation on Statin Adherence and Discontinuation
by: Christopher LaFratte, et al.
Published: (2023-09-01)

Relative contributions of statin intensity, achieved low-density lipoprotein cholesterol level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes: population based cohort study
by: Ji Yoon Kim, et al.
Published: (2022-02-01)

Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
by: Ulrich Laufs, et al.
Published: (2019-04-01)

Evaluation of statin use on LDL cholesterol levels in Turkey: A systematic review
by: Pınar Kızılırmak, et al.
Published: (2020-03-01)

Gender Difference in Statin Intervention on Blood Lipid Control among Patients with Coronary Heart Disease
by: Chun-Yen Chen, et al.
Published: (2013-06-01)

Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins
by: Yosuke Furuya, et al.
Published: (2016-06-01)

Statin Use and Stroke Rate in Older Adults With Atrial Fibrillation: A Population‐Based Cohort Study
by: Bisan Shweikialrefaee, et al.
Published: (2023-06-01)

Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease
by: Chieh‐Li Yen, et al.
Published: (2022-10-01)

From intensive statins to intensive lipid lowering: Amplitude of low-density lipoprotein-cholesterol lowering is the core for atherosclerosis cardiovascular disease prevention
by: Daoquan Peng
Published: (2018-01-01)

Statins in Healthy Adults: A Meta-Analysis
by: Lee Sandwith, et al.
Published: (2021-06-01)

Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi‐Ethnic Study of Atherosclerosis)
by: Michael D. Miedema, et al.
Published: (2018-06-01)

Association of Contemporary Statin Pretreatment Intensity and LDL-C Levels on the Incidence of STEMI Presentation
by: Ziv Dadon, et al.
Published: (2021-11-01)

Low-density lipoprotein cholesterol, statin therapy, and cerebral microbleeds: The CIRCLE study
by: Yuqi Zhao, et al.
Published: (2023-01-01)

The tangled web of dyslipidemia and cancer: Is there any association?
by: Sina Neshat, et al.
Published: (2022-01-01)

Effect of 2018 American College of Cardiology/American Heart Association Guideline Change on Statin Prescription for People Living with HIV
by: Meng Pan, et al.
Published: (2023-06-01)

PCSK9 Inhibitor Therapy as an Alternative for Statin Intolerance
by: K. O. Shnaider, et al.
Published: (2023-12-01)

Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan
by: Hiroshi Yokomichi
Published: (2017-03-01)

Target Low-Density Lipoprotein-Cholesterol and Secondary Prevention for Patients with Acute Myocardial Infarction: A Korean Nationwide Cohort Study
by: Ju Hyeon Kim, et al.
Published: (2022-05-01)

Situational Analysis of Low-density Lipoprotein Cholesterol Control and the Use of Statin Therapy in Diabetes Patients Treated in Community Hospitals in Nanjing, China
by: Xiao-Jun Ouyang, et al.
Published: (2018-01-01)

The DYSlipidemia International Study (DYSIS)-Egypt: A report on the prevalence of lipid abnormalities in Egyptian patients on chronic statin treatment
by: Adel El Etriby, et al.
Published: (2013-09-01)

Aspirin and statins: possibilities for joint improvement of prognosis in cardiovascular disease
by: К. G. Pereverzeva, et al.
Published: (2019-01-01)

Coronary Artery Calcium Score–Directed Primary Prevention With Statins on the Basis of the 2018 American College of Cardiology/American Heart Association/Multisociety Cholesterol Guidelines
by: Jana Taron, et al.
Published: (2021-01-01)

Author reply to technical comment on: Rachamin et al. Statin treatment and LDL target value achievement in Swiss general practice
by: Yael Rachamin, et al.
Published: (2020-11-01)

Eligibility for Statin Treatment in Korean Subjects with Reduced Renal Function: An Observational Study
by: Byung Sub Moon, et al.
Published: (2016-09-01)

Contemporary data on low-density lipoprotein cholesterol target value attainment and distance to target in a cohort of 57,885 statin-treated patients by country and region across the world
by: Anselm K. Gitt, et al.
Published: (2016-12-01)

Current perspectives on the use of statins in the treatment of dyslipidaemic patients: focus on pitavastatin
by: Lale Tokgözoglu, et al.
Published: (2020-06-01)

Forty‐eight weeks of statin therapy for type 2 diabetes mellitus patients with lower extremity atherosclerotic disease: Comparison of the effects of pitavastatin and atorvastatin on lower femoral total plaque areas
by: Xieda Zhou, et al.
Published: (2021-07-01)